In 2015, a Cognitive Vitality Report released by the Alzheimers Drug Discovery Foundation stated that two multi-year treatment trials had found that epithalamin, from which epitalon is isolated, had imparted no severe adverse events in older adults, and that preclinical trials supported a favorable safety profile.35 Ten years later, a systematic review published in 2025 stated that information regarding critical issues about this peptides safety is missing.1 In terms of human trials, the best case we have in support of epitalons safety is a 2002 trial involving 162 patients in which no one in the epitalon group reported serious side effects.36 At the same time, the U.S
The reduced hypoglycemia risk compared to insulin or sulfonylureas makes dual agonism particularly attractive in this population
Enhancement of Mouse Sciatic Nerve Regeneration by the Long Chain Fatty Alcohol, N-Hexacosanol
reported that the muscle glycogen levels when inhibiting GSK-3 did not cause major fluctuation when comparing to control in GSK-3 knock-in animals 22
While a promising approach, future work to address product stability and efficacy in larger eyes is needed for further development
References 1From Regeneration to Analgesia: The Role of BPC-157 in Tissue Repair and Pain Management | Yuan et al